Month: September 2025

The new age of cannabis dosing with gummies is sweeping the globe, but a quality crisis threatens the industry's pharmaceutical credibility. What started in Australia has quickly moved to the UK and now Germany , where…

Europe’s emerging medical cannabis oil market is projected to reach an estimated value of nearly $2.4 billion by 2032 according to a new market analysis by Astute Analytica. The market…

Somaí publishes a technical article with the University of Lusófona. The IG Hanf (Hemp Association) welcomes the progress of cannabis legalization in Switzerland. Bloomwell warns against restrictions on telemedicine. Grünhorn…

Introduction Cannabis sativa L., a member of the family Cannabaceae, contains two important crop species that are cultivated worldwide: cannabis (marijuana) for its medicinal and psychotropic properties, and hemp as a…

Harmony Biosciences’ transdermal cannabidiol ZYN002 suffered a setback as a Phase III trial failed to meet the primary endpoint in a Fragile X Syndrome  trial, with the biotech blaming a…

Currently, no permits can be issued for the import of cannabis for medical purposes into Germany. The Federal Institute for Drugs and Medical Devices (BfArM) confirmed this in response to…

Last week, I had the privilege of attending Pharmaforum Madrid 2025, one of Europe's most significant gatherings of pharmaceutical innovators, engineers, and executives. The energy was palpable, focused squarely on the…